BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Allergy to pollen
,
Heart
,
Biofuel
,
Phenobarbital
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
molecular chaperone
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Monocytic gene expression in response to treatment with M. tuberculosis Chaperonin 60.1
Peripheral blood mononuclear cells from rheumatoid arthritis patients treated with chaperonin 10
Dermal fibroblasts responses to different treatments
Ovarian cancer MDAH-2774 cells treated with recombinant human STIP1
Ovarian cancer SK-OV-3 cells treated with recombinant human STIP1
Explore Curated Studies Results
Literature
Most Relevant Literature
Structural and Kinetic Views of Molecular Chaperones in Multidomain Protein Folding.
Enhanced production of recombinant proteins in Corynebacterium glutamicum using a molecular chaperon…
COSMC expression as a predictor of remission in IgA nephropathy.
Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence.
Biosynthetic Protein Folding and Molecular Chaperons.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, …
Study of SNX-5422 in TP53 Null Cancers
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL
Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors
Safety and Activity of SNX-5422 Plus Ibrutinib in CLL
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ